1 / 5 of the novel coronavirus patients with mace early reading died, which may be related to autoantibodies

1 novel coronavirus pneumonia: novel coronavirus pneumonia novel coronavirus pneumonia novel coronavirus pneumonia is not suitable for the prevention of novel coronavirus pneumonia on the 11 th, who is launching the novel coronavirus pneumonia routine conference.

Michael Ryan, who is responsible for the health emergency project, said that dexamethasone should be used under medical supervision and not suitable for the prevention of novel coronavirus pneumonia, and should be applied to the novel coronavirus pneumonia critical patients.

Dexamethasone is a very powerful anti-inflammatory drug, which can save severe patients with pulmonary and peripheral cardiovascular inflammation, possibly because it can reduce inflammation and ensure that the lungs continue to deliver oxygen to the blood.

2, novel coronavirus pneumonia confirmed novel coronavirus pneumonia in 9966 cases, and 9966 cases were confirmed in 6887791 cases.

The data of the updated data of the French Public Health Bureau in September 10th showed that 6887791 cases were confirmed by novel coronavirus pneumonia in France, and 9966 cases were confirmed newly compared with the previous day.

There were 81 new deaths, with a total of 115442 deaths.

At present, 10115 confirmed cases in France are hospitalized for treatment, and 3651 new cases have been hospitalized in the past seven days.

Novel coronavirus pneumonia accounted for 2151 cases, 44 cases decreased compared with the previous day, 3 cases.

The death of novel coronavirus 1/5 patients may be related to autoantibodies.

A large international study published in the journal Science immunology in August 16, 2021 also showed that when some people were infected with novel coronavirus pneumonia, there was an autoantibody in the body, which would attack their own immune defense system.

It has become a key factor leading to severe disease and even death.

In order to emphasize its reaction mechanism, some scientists jokingly call autoantibodies “rogue” antibodies.

Novel coronavirus pneumonia was found in September 2020 in a team led by Jean Laurent Casanova, Rockefeller University in New York.

More than 10% of the 987 new severe pneumonia patients had antibodies against the autoimmune system and interfered with interferon 1.

Interferon 1 played a key role in the fight against viral infection.

The research team focused on detecting “rogue” antibodies.

After studying 3595 severe novel coronavirus pneumonia patients in 38 countries, 13.6% of the patients detected “rogue” antibodies.

Among them, the proportion of patients under 40 was 9.6%, and the proportion of patients aged 80 years or above was 21%.

There were rogue antibodies in 18% of the dead patients.

He also found that “rogue” antibodies are more common in men than in women, which may be a factor that male patients with novel coronaviruss are more prone to severe diseases.

The research team focused on detecting “rogue” antibodies.

After studying 3595 severe novel coronavirus pneumonia patients in 38 countries, 13.6% of the patients detected “rogue” antibodies.

Among them, the proportion of patients under 40 was 9.6%, and the proportion of patients aged 80 years or above was 21%.

There were rogue antibodies in 18% of the dead patients.

3595 novel coronavirus pneumonia patients had the proportion of “rogue” antibody..